Tag: OBI

Intas Pharmaceuticals and Accord BioPharma Become One of the Largest Global Suppliers of Pegfilgrastim with Acquisition of UDENYCA®

AHMEDABAD, India, Aug. 7, 2025 /PRNewswire/ -- Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as...

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses,...

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses,...

DONALD M. SOFFER, VISIONARY DEVELOPER, PHILANTHROPIST, AND FAMILY PATRIARCH, PASSES AWAY AT 92

Link here for image AVENTURA, Fla., July 20, 2025 /PRNewswire/ -- Donald M. Soffer, the founder of Aventura, visionary behind some of South Florida's most iconic developments,...

QuickLogic Announces the Passing of Board Director Christine Russell

SAN JOSE, Calif., July 14, 2025 /PRNewswire/ -- QuickLogic Corporation (NASDAQ: QUIK), today announced with great sadness that Christine Russell, Board Director, died unexpectedly...

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

Airmedic Honours the Memory of Its Team and Patient Lost During a Medical Evacuation Operation

SAINT-HUBERT, QC, June 27, 2025 /CNW/ - Today, the Coroner's Office released the identities of the three crew members and the patient who perished...

Four Michigan students advance to national finals of the Mott Million Dollar Challenge in Flint

Long Beach Community Care Campus Expansion Advances with $10 Million Investment from Centene Foundation and Health Net

Oh!mino Releases New Industry Report on Athletes Replacing Supplement Stacks with All-in-One EAA Formulas

Tag: OBI

Intas Pharmaceuticals and Accord BioPharma Become One of the Largest Global Suppliers of Pegfilgrastim with Acquisition of UDENYCA®

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

DONALD M. SOFFER, VISIONARY DEVELOPER, PHILANTHROPIST, AND FAMILY PATRIARCH, PASSES AWAY AT 92

QuickLogic Announces the Passing of Board Director Christine Russell

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

Airmedic Honours the Memory of Its Team and Patient Lost During a Medical Evacuation Operation

Explore

Press Releases

News & Opinion

Living

Others

Follow us